Summary
Interstitial brachytherapy with low energy radionuclides is becoming widely used in conjunction with external beam radiotherapy in the treatment of primary malignant gliomas of the brain. Few radiobiological studies have been carried out with low dose rate brachytherapy for brain tumors. Since we have recently developed a non-invasive low dose rate radiotherapy model for the treatment of transplantable 9L gliosarcoma growing in the rat brain, we carried out a series of radiobiological studies to determine the dose rate effect on the tumor and normal brain tissue. Using TCD50 (the radiation dose to control 50% tumor control) as the endpoints, we obtained the results indicating that the tumor control rate was highly dependent on the dose rate and the total dose delivered to the tumor. The TCD50 of dose rates ranging from 100 cGy/min, 120 cGy/hr, and 40 cGy/hr were 25 Gy, 80 Gy, and 100 Gy, respectively. The normal tissue effects were most pronounced with high dose rate irradiation (100 cGy/min). The LD50 for high dose rate irradiation to the whole brain was 29 Gy. In contrast, the majority of animals treated with low dose rate radio-therapy behaved quite normal up to a year follow-up. The late histopathological changes of the irradiated brain usually consisted of vascular and white matter necrosis, although the extent of such changes showed a considerable individual variation within the long-term survivors.
Similar content being viewed by others
References
Kim JH, Hilaris B: Iodine-125 source in interstitial tumor therapy: clinical and biologic considerations. Am J Roentg Rad Ther & Nuc Med 123: 163–169, 1975
Mundinger F, Weigel K: Long-term results of stereotactic interstitial curietherapy. Acta Neurochir 33: 367–371,1984
Gutin PH, Leibel SA, Wara WM, et al.: Recurrent malignant Gliomas: survival following interstitial brachytherapy with high activity iodine-125 sources. J Neurosurg 67: 864–873, 1987
Glicksman A, Leith J: Radiobiological basis of low dose rate radiotherapy. Oncology 2: 10–14,1988
Hill RP, Bush RS: The effect of continuous or fractionated irradiation on a murine sarcoma. Brit J Radiol 46: 167–174, 1973
Fu KK, Phillips TL, Kane LJ, Smith J: Tumor and normal tissue response to irradiation in vivo: variation with decreasing dose rates. Radiology 114: 709–716, 1975
Kim JH, Alfieri AA, Kim SH, Bravo S: Transplantable gliosarcoma in the rat: a noninvasive low dose rate radiotherapy model. Endocuritherapy/Hyper Oncol 3: 47–53, 1987
Wallen CA, Michaelson SM, Wheeler KT: Evidence for an unconventional radiosensitivity of rat 9L subcutaneous tumors. Radiat Res 84: 529–541, 1978
Wheeler KT, Baker M, Wallen CA, Kimler BF, Henderson SD: Methods in tumor biology: tissue culture and animal tumor models. In Press
Zook BC, Bradley EW, Casarett CW, Rogers CC: Pathologic findings in canine brain irradiated with fractionated fast neutrons or photons. Radiat Res 84: 562–578, 1980
Sheline G: Radiation therapy of brain tumors. Cancer 39: 873–881,1977
Fike JR, Cann CE, Davis RL, Borcich JK, Phillips TL, Russell LB: Computed tomography analysis of the canine brain: effects of hemibrain x-irradiation. Radiat Res 99: 294–310,1984
Anderson LL: Physical optimization of after-loading techniques. Strahlentherapie 161: 264–269, 1985
Withers HR, Peters LJ, Kogelnik HD: The pathobiology of late effects of irradiation. In: Meyn RE, Withers HR (Eds) Radiation biology in cancer research. Raven Press, New York, 1980, pp 439–448
Reinhold HS, Hopewell JW: Late changes in the architecture of blood vessels of the rat brain after irradiation. Br J Radiol 53: 693–696, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kim, J.H., Alfieri, A.A., Rosenblum, M. et al. Low dose rate radiotherapy for transplantable gliosarcoma in the rat brain. J Neuro-Oncol 9, 9–15 (1990). https://doi.org/10.1007/BF00167063
Issue Date:
DOI: https://doi.org/10.1007/BF00167063